Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatmentsAlfonso Cortés, Alfredo Carrato, José L. Casado et al.|European Journal of Cancer|2022Cited by 30
A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast CancerLuís Manso, Miguel Quintela-Fandiño, Rodrigo Sánchez-Bayona et al.|Cancer Research Communications|2025Cited by 2
Abstract OT2-19-08: Phase IB/II trial of palbociclib and binimetinib in advanced triple-negative breast cancer with hyperactivation of ERK and/or CDK4/6Luís Manso, Miguel Quintela-Fandiño, Alfonso Cortés et al.|Cancer Research|2022Cited by 1
Figure S1 from A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast CancerLuís Manso, Miguel Quintela-Fandiño, Rodrigo Sánchez-Bayona et al.|Unknown|2025Cited by 0
Figure 1 from A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast CancerLuís Manso, Miguel Quintela-Fandiño, Rodrigo Sánchez-Bayona et al.|Unknown|2025Cited by 0